Our Services
Medical Information
Helpful Resources
Published on: 2/2/2026
Pregnancy can still occur in the 40s and early 50s, so effective contraception remains essential through perimenopause and until menopause is confirmed, typically 12 months without a period after age 50, to lower the higher risks of later-age pregnancy and to support STI protection when needed. There are several factors to consider. See below for how to choose between hormonal and non-hormonal methods, when it may be safe to stop, the role of condoms, medical conditions that affect safety, and emotional factors, any of which could influence your best next step with your clinician.
Many women are surprised to learn that pregnancy is still possible in the 40s and early 50s. During perimenopause—the years leading up to menopause—hormones fluctuate, periods become irregular, and fertility declines, but it does not disappear overnight. This is why contraception effectiveness continues to matter, even when pregnancy feels unlikely.
This article explains why protection is still important, how different methods perform during perimenopause, and how women can make informed, calm decisions that support both physical and emotional health.
Perimenopause is the transition phase before menopause, which is officially diagnosed after 12 consecutive months without a period. For many women, perimenopause lasts 4–10 years and often extends into the early 50s.
Common changes include:
What matters for contraception is this: ovulation can still happen unpredictably. Even with long gaps between periods, a single ovulation can lead to pregnancy.
There is a widespread myth that pregnancy "can't happen" after a certain age. In reality:
From a medical perspective, unintended pregnancy later in life carries higher health risks, including:
This is why healthcare organizations consistently state that effective contraception should be used until menopause is confirmed.
Contraception effectiveness refers to how well a method prevents pregnancy over time, especially with typical (real-world) use.
Effectiveness depends on:
During perimenopause, effectiveness becomes even more important because fertility is unpredictable rather than absent.
Not every method is suitable for every woman. Health history, comfort, and risk factors all matter. Below is a clear overview of commonly used options.
These may help with both contraception and symptom control, but they are not for everyone.
Examples include:
Potential benefits:
Considerations:
These can be a good fit for women who prefer to avoid hormones.
Examples include:
Potential benefits:
Considerations:
While pregnancy prevention is often the focus, condoms play an important additional role.
They:
STI rates have been rising in adults over 50, largely due to reduced condom use. Even in long-term relationships, protection may still be relevant depending on circumstances.
Sexual health in perimenopause is not just physical. Past experiences, stress, and trauma can shape how protection is used—or avoided.
Some women may notice:
If past traumatic experiences may be affecting your intimate health or decision-making, a confidential sexual trauma symptom assessment can help you better understand how these experiences might still be impacting your well-being today.
Addressing emotional well-being can improve both quality of life and confidence in making protection choices.
In general medical guidance:
Because hormonal methods can mask natural periods, a doctor may use blood tests or age-based guidelines to help decide when contraception is no longer needed.
Stopping too early can lead to unintended pregnancy, while stopping too late may mean unnecessary medication. This balance is best assessed with professional guidance.
Let's clear up a few misunderstandings:
"I'm too old to get pregnant."
Pregnancy is less likely, but still possible until menopause.
"Irregular periods mean I'm infertile."
Irregular does not mean inactive ovaries.
"Contraception is dangerous at my age."
Many options are safe when chosen carefully and monitored.
Understanding the facts helps women make calm, confident decisions rather than reacting to fear or misinformation.
There is no single "best" method—only the best fit for you.
A good decision considers:
A healthcare professional can help weigh benefits and risks without pressure or judgment.
Any symptoms that feel severe, sudden, or life-threatening should be addressed immediately. This includes:
Even for less urgent concerns, it is important to speak to a doctor before starting, stopping, or changing contraception. A clinician can ensure that your method remains safe and effective as your body changes.
Perimenopause is not an ending—it is a transition. Continuing to think about contraception effectiveness in your 50s is not about fear, but about choice, safety, and self-respect.
With clear information, supportive care, and attention to both physical and emotional health, women can navigate this stage with confidence. Protection, when chosen thoughtfully, supports not just pregnancy prevention, but overall well-being during a time of significant change.
(References)
* Hamoda H, Panay N, Pedder H, Currie H, Abernethy K, British Menopause Society and Women's Health Concern. Management of the menopause: an updated British Menopause Society and Women's Health Concern 2020 recommendations for hormone replacement therapy. Post Reprod Health. 2020 Dec;26(4):180-203. doi: 10.1177/2053019620950624. Epub 2020 Sep 11. PMID: 32912169.
* The North American Menopause Society. The 2020 menopause position statement of The North American Menopause Society. Menopause. 2020 Sep;27(9):976-992. doi: 10.1097/GME.0000000000001618. PMID: 32800315.
* Johnson A, Roberts L, Elkins G. Therapeutic strategies for menopausal symptoms: a clinical review. JAMA. 2019 Aug 13;322(6):531-541. doi: 10.1001/jama.2019.10251. PMID: 31408021.
* Shifren JL, Gass MLS, NAMS Board of Trustees. The North American Menopause Society position statement on nonhormonal management of menopause-associated vasomotor symptoms. Menopause. 2023 Apr 1;30(4):379-402. doi: 10.1097/GME.0000000000002161. PMID: 36877668.
* El Khoudary SR, Aggarwal B, Beckie TM, Cahill E, Delville CL, Johnson AE, Komaroff E, Langer RD, Miller VM, Neal-Perry G, Pothuloori M, Shufelt C, Tabatabai S, Taub PR, The North American Menopause Society, The American Society for Preventive Cardiology. Cardiovascular health during the menopausal transition: The North American Menopause Society and the American Society for Preventive Cardiology position statement. Menopause. 2020 Dec;27(12):1323-1341. doi: 10.1097/GME.0000000000001648. PMID: 33264103.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.